Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
A) Synaptic NMDAR signalling suppresses the intrinsic apoptosis cascade at multiple levels. Synaptic N-methyl-D-aspartate receptor (NMDAR) activity protects neurons against apoptosis in a manner that is independent of the type of cellular insult because it suppresses the core apoptotic pathway. Transcriptional suppression of the BH3-only domain gene Puma by activation of synaptic NMDARs is a key event upstream of cytochrome c release (A) , . Up-regulation of a battery of nuclear Ca2+-regulated genes (green box) is also strongly protective , and probably also acts upstream of cytochrome c release, as it inhibits insult-induced mitochondrial membrane depolarization (B). Downstream of cytochrome c release, transcriptional suppression of components of the caspase cascade, such as Apaf-1, Caspase-9 and Caspase-3, also slows the apoptotic process (C) or raises the amount of mitochondrial cytochrome c release that is required to initiate apoptosis (as cytochrome c’s cytoplasmic target is Apaf-1) . Synaptic NMDAR activity also induces inactivation of the pro-death transcription factors FOXO and p53 (D) , , , and the subsequent suppression of the genes whose expression they regulate. Finally, transcription factors that have been shown to be important targets for NMDAR-dependent pro-survival signals are shown, namely CREB, NFAT and NFI-A (E) , , .B) Synaptic NMDAR signalling boosts intrinsic antioxidant defences. A schematic showing the effect of synaptic activity-induced changes in transcription on the thioredoxin (Trx)-peroxiredoxin (Prx) system. The dotted arrows indicate activity-dependent signalling events, which are collectively shaded in green. Briefly, reduction of peroxide levels is executed via the transfer of electrons from NADPH to peroxides through the redox-active sulfhydryl (-SH) groups of thioredoxin reductase, Trx and Prxs (the major two-cysteine Prx sub-type is shown). The catalytic redox-active cysteine residue of Prx (Sc, red) reduces peroxide, and is oxidized to cysteine sulfenic acid (SCOH). The resolving cysteine (SR, green) of a different Prx molecule then forms a disulfide bond with Prx-SCOH, thereby eliminating H2O. This intermolecular disulfide bond is then reduced by Trx, whose two-cysteine active site is reduced by Trx reductase. However, if levels of peroxide are too high, the – SCOH group becomes hyperoxidized to –SO2H (cysteine sulfinic acid). –SO2H is not a substrate for the resolving cysteine –SCH or for Trx. Instead, sulfiredoxin (and possibly sestrin 2) catalyses the reduction of hyperoxidized Prx-SO2H, returning it to the Trx cycle. Synaptic activity triggers the events shown to both enhance Trx activity and boost the reduction of hyperoxidized Prxs. These include the transcriptional activation of sulfiredoxin and sestrin 2, and the transcriptional suppression of Txnip, the gene encoding a the Trx inhibitor thioredoxin-interacting protein (Txnip). Bim (bcl2-interacting mediator of cell death); Fasl (fas antigen ligand); Apaf1 (apoptotic peptidase activating factor 1); CREB (cAMP responsive element binding protein); NFAT (nuclear factor of activated T-cells); NFI-A (nuclear factor I/A); Atf3 (activating transcription factor 3); Bcl6 (B-cell leukemia/lymphoma 6); Btg2 (B-cell translocation gene 2); Gadd45beta, GADD45gamma (growth arrest and DNA damage induced gene 45 gamma and beta, respectively); Nr4a1 (nuclear receptor subfamily 4, group A, member 1); Npas4 (neuronal PAS domain protein 4); Inhbb (Inhibin beta-A).